Correspondence
52 Articles |
-
Correspondence to “Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus”
Smith, P.K., Lesslar, O. and Price, D.B. et al. Allergy. First published: 06 August 2022
-
Reply to correspondence to ‘Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus’
Hagemann, J., Zuberbier, T., Walter Canonica, G., et al. Allergy. First published: 06 August 2022
-
Bacillus Calmette–Guérin vaccination to prevent childhood asthma: A revised meta-analysis
Pittet, L.F. and Curtis, N. Allergy. First published: 30 June 2022
-
Reply to correspondence: Basophil reactivity to BNT162b2 in COVID-19 convalescence
Labella, M., Céspedes, J.A., Doña, I., et al. Allergy. First published: 30 June 2022
-
Comment on EAACI guideline: Anaphylaxis (2021 update)
Miceli Sopo, S., Sinatti, D., Mastellone, F., Bersani, G. and Gelsomino, M. et al. Allergy. First published: 30 June 2022
-
Reply to the correspondence: Bacillus Calmette-Guérin vaccination to prevent childhood asthma—A revised analysis
Navaratna, S., Burgess, J., Waidyatillake, N., et al. Allergy. First published: 30 June 2022
-
Reply to: “Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients”
Renert-Yuval, Y. and Guttman-Yassky, E. Allergy. First published: 30 June 2022
-
Correspondence to " Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis"
Kelleher, M.M., Cro, S., Phillips, R., et al. Allergy. First published: 29 May 2022
-
Reply to correspondence: Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis
Zhong, Y., Samuel, M., van Bever, H. and Tham, E.H. Allergy. First published: 29 May 2022
-
Food-induced immediate response of the esophagus: A first report in the pediatric age
Votto, M., Naso, M., De Filippo, M., et al. Allergy. First published: 24 January 2022
-
Successful administration of second dose of BNT162b2 COVID-19 vaccine in two patients with potential anaphylaxis to first dose
Cahill, J.A. and Kan, M.sss Allergy. First published: 29 December 2021
-
β2-adrenergic agonists and doping: Where do we stand?
Lourenço, O., Cardoso, A., Mónico, B., Gama, J.M.R., Neiva, H.P. and Marinho, D.A. Allergy. 2021; 76: 2320-2321
-
Role of activation of the coagulation system in the pathogenesis of urticaria
Yasuma, T., D’Alessandro-Gabazza, C.N., Kobayashi, T., Morser, J. and Gabazza, E.C. Allergy. 2021; 76: 3243-3244
-
Silicosis: Pathogenesis and utility of animal models of disease
Walters, E.H. and Shukla, S.D. Allergy. 2021; 76: 3241-3242
-
Beta2-adrenergic agonists can enhance intense performance and muscle strength in healthy individuals
Hostrup, M., Jessen, S., Backer, V., Bangsbo, J. and Jacobson, G.A. Allergy. 2021; 76: 2318-2319
-
COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: “Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines”
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1943-1944
-
Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines
Borgsteede, S.D., Geersing, T.H. and Tempels-Pavlica, Ž. Allergy. 2021; 76: 1941-1942
-
COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: “COVID-19 vaccine anaphylaxis: PEG or not?”
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1938-1940
-
COVID-19 vaccine anaphylaxis: PEG or not?
Krantz, M.S., Liu, Y., Phillips, E.J. and Stone, C.A., Jr Allergy. 2021; 76: 1934-1937
-
Successful rapid desensitization in a glioma patient with procarbazine-mediated anaphylaxis
Hutten, E.M., Lambeck, A.J.A., Dijkstra, H., et al. Allergy. 2021; 76: 1932-1933
-
Reply to “Acute scrotum in a 8- year- old Italian child caused by extraintestinal anisakiasis in a seaside area
Morishima, R. Allergy. 2021; 76: 1603-1603
-
Acute scrotum in a 8-year-old Italian child caused by extraintestinal anisakiasis in a seaside area
Centonze, A., Capillo, S., Mazzei, A., et al. Allergy. 2021; 76: 1601-1602
-
Reply to: “Include desensitization to radiocontrast media in the diagnostic algorithm”
Brockow, K. Allergy. 2021; 76: 1304-1305
-
Include desensitization to radiocontrast media in the diagnostic algorithm of radio contrast media hypersensitivity
Bjørbak Alnæs, M. Allergy. 2021; 76: 1302-1303
-
Reply to “Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy”
Stranzl, T., Ipsen, H., Christensen, L.H., et al. Allergy. 2021; 76: 1300-1301
-
Inferring clinical relevance of Der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy
González-Pérez, R. and Poza-Guedes, P. Allergy. 2021; 76: 1298-1299
-
Asthmatic patients and COVID-19: Different disease course?
Alberca, R.W., Yendo, T., Aoki, V. and Sato, M.N. Allergy.2021; 76: 963-965
-
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
Heffler, E., Detoraki, A., Contoli, M., et al. Allergy.2021; 76: 961-962
-
Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
Kow, C.S., Capstick, T. and Hasan, S.S. Allergy.2021; 76: 959-960
-
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology
Bhalla, A., Mukherjee, M., Radford, K., et al. Allergy.2021; 76: 957-958
-
Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification
Carli, G., Cecchi, L., Stebbing, J., Parronchi, P. and Farsi, A. Allergy.2021; 76: 955-956
-
Update on asthma prevalence in severe COVID-19 patients
Morais-Almeida, M., Barbosa, M.T., Sousa, C.S., Aguiar, R. and Bousquet, J. Allergy.2021; 76: 953-954
-
Comment on: Bilò MB, Pravettoni V, Mauro M, Bonadonna P. Treating venom allergy during COVID-19 pandemic
Martínez-Lourido, E., Otero, A., Armisén, M. and Vidal, C. Allergy, 76: 951-952
-
Treating venom allergy during COVID-19 pandemic
Bilò, M.B., Pravettoni, V., Mauro, M. and Bonadonna, P. Allergy.2021; 76: 949-950
-
Reply to Dr. Vincenzo Patella et al. Could anti-tubercular vaccination protect against COVID-19 infection?
Ozdemir, C., Kucuksezer, U.C. and Tamay, Z.Ü. Allergy. 2021; 76: 946-948
-
Could anti-tubercular vaccination protect against COVID-19 infection?
Patella, V., Florio, G., Brancaccio, R. and Delfino, G. Allergy.2021; 76: 942-945
-
Reply to correspondence: Silica-related diseases in the modern world: A role for self-DNA sensing in lung inflammatory
Chambers, D.C. and Hoy, R.F. Allergy.2020; 75: 3011-3011
-
Silica-related diseases in the modern world: A role for self-DNA sensing in lung inflammatory diseases
Togbe, D., Benmerzoug, S., Jacobs, M., Ryffel, B. and Quesniaux, V.F.J. Allergy.2020; 75: 3009-3010
-
Preschool wheeze: Challenges and research prospects reply to: Dr Jartti and Colleagues; in response to our manuscript entitled: Medical algorithm: Diagnosis and treatment of preschool asthma
Bush, A. and Saglani, S. Allergy. 2020; 75: 2718-2718
-
Reply to: Medical algorithm: Diagnosis and treatment of preschool asthma
Jartti, T., Papadopoulos, N.G., Feleszko, W. Allergy.2020; 75: 2716-2717
-
Detection of peanut allergens in serum: circumventing the inhibitory effect of immunoglobulins
Koppelman, S.J., Witteveen, M., JanssenDuijghuijsen, L., Baumert, J.L., Witkamp, R.F. and van Norren, K. Allergy.2020; 75: 1835-1836
-
Relationship between early pubertal maturation and asthma: The role of adiposity rebound in early childhood
Chen, Y.-C. and Lee, Y.L. Allergy.2020; 75: 999-1000
-
Relationship between early pubertal maturation and asthma
Ichikawa, G., Arisaka, O., Nakayama, K., Koyama, S. and Yoshihara, S. Allergy.2020; 75: 998-998
-
Reply to correspondence: "Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments"
Manti, S., Licari, A., Leonardi, S., Marseglia, G.L. and Baraldi, E. Allergy.2020; 75: 1531-1532
-
Correspondence to "Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments"
Jartti, T., Smits, H.H., Bønnelykke, K., et al. Allergy.2020; 75: 1529-1530
-
Reply to: "Arginase inhibitors: An alternative in treatment of obese asthma?"
Meurs, H., Zaagsma, J., Maarsingh, H. and van Duin, M. Allergy.2020; 75: 1527-1528
-
Arginase inhibitors: An alternative in treatment of obese asthma?
Felix, M.M.R. and Kuschnir, F.C. Allergy.2020; 75: 1525-1526
-
Role of routine cephalosporin allergy testing in surgical site infection reduction bundles
Fox, W.E. and Scott, M.J.Allergy.2019; 74: 1820-1820
-
Stability of neuromuscular blocking drugs used for skin testing
Baldo B. A. Allergy.2019; 74: 1201-1202